AI Science Tracker
EN

Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics Profiles.

Affiliation not stated in the reviewed material · 26 Jun 2020 · medicine

Discovery

Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics Profiles.

Source check: Source checked. Not independent scientific confirmation.

Finding: XGBoost with feature selection yields 118 validated cell-line drug-response models for 62 drugs across five cancer types using four omics profiles; validation is on the source pharmacogenomic datasets, not clinical patient response. External replication and prospective utility were not established in the reviewed material.

Technology: XGBoost polygenic models with feature selection trained on multi-omics pharmacogenomic profiles

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
XGBoost polygenic models with feature selection trained on multi-omics pharmacogenomic profiles
Test and result
XGBoost with feature selection yields 118 validated cell-line drug-response models for 62 drugs across five cancer types using four omics profiles; validation is on the source pharmacogenomic datasets, not clinical patient response.
Limitation / still unknown
External replication, causal effects and prospective utility were not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://mdpi-res.com/d_attachment/biomolecules/biomolecules-10-00963/article_deploy/biomolecules-10-00963.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.